Company Overview of Speedel Pharma AG
Speedel Pharma AG was acquired by Novartis AG. Speedel Pharma AG develops drugs for the treatment of cardiovascular and metabolic diseases. The company was founded in 1998 and is based in Basel, Switzerland.
Founded in 1998
41 61 206 40 00
41 61 206 40 01
Key Executives for Speedel Pharma AG
Speedel Pharma AG does not have any Key Executives recorded.
Similar Private Companies By Industry
|FunZyme BioTechnologies S.A.||Europe|
|Novartis Animal Health Inc.||Europe|
|TopoTarget Switzerland S.A.||Europe|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
To contact Speedel Pharma AG, please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.